Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation

In a step towards addressing India’s critical need for organ donors, Mankind Pharma Limited, one of India’s leading pharmaceutical companies, has launched its nationwide public awareness campaign “Angdaan Mahadaan”, with a goal of inspiring 1 crore Indians to pledge for organ donation.

The campaign was launched in the presence of transplant specialists and dignitaries from the National Organ and Tissue Transplant Organisation (NOTTO), who came together to raise public awareness, dispel myths and highlight the transformative impact of organ donation.

Through “Angdaan Mahadaan”, Mankind Pharma aims to create greater awareness, address myths and misconceptions, and motivate millions of Indians to turn public awareness into meaningful action.

The campaign was launched at an Organ Donation Awareness Event hosted by Mankind Pharma, engaging more than 25,000 Mankindians, their families and extended communities. The event featured sessions on the realities of organ donation, myths and facts surrounding transplantation, and the current organ donation landscape in India.

The event brought together Dr D S Ray, chief nephrologist and head, renal transplant programme, R N Tagore International Institute of Cardiac Sciences, Narayana Health, Kolkata; Dr. Abhideep Chaudhary, chairman and HOD, HPB Surgery and Liver Transplantation, BLK-Max Super Speciality Hospital, New Delhi; and Dr. Kanika Rastogi, National Organ and Tissue Transplant Organisation (NOTTO), New Delhi to raise public awareness about the importance of organ donation.

“To give is to live beyond yourself. Through Angdaan Mahadaan, we want to inspire people across India to recognise the extraordinary power of a simple decision: the decision to give someone another chance at life. Our ambition is to motivate 1 crore Indians to pledge for organ donation and make this a movement that creates a lasting legacy of hope,” said Rajeev Juneja, vice chairman and managing director, Mankind Pharma Ltd.

  • Related Posts

    GLP-1 injections recalled across the US over sterility concerns

    A nationwide recall of compounded tirzepatide injections in the United States has raised fresh concerns about the safety of weight-loss medicines. The recall, initiated by Apothecary Pharma LLC over concerns…

    Govt allows third-party agencies to conduct departmental inspections

    Bengaluru: The government has directed various departments to engage authorised third-party agencies to carry out scheduled inspections, audits and certification activities in areas where staff shortages have delayed regulatory checks.…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    GLP-1 injections recalled across the US over sterility concerns

    GLP-1 injections recalled across the US over sterility concerns

    Govt allows third-party agencies to conduct departmental inspections

    Govt allows third-party agencies to conduct departmental inspections

    Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

    Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

    Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis

    Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis

    Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher

    Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher

    Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

    Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires